Preface |
|
xxiii | |
|
PART I: BASIC ECONOMICS TOOLS |
|
|
1 | (72) |
|
|
1 | (19) |
|
The Relevance of Health Economics |
|
|
1 | (7) |
|
The Size and Scope of the Health Economy |
|
|
1 | (6) |
|
The Economic Side to Other Health Issues |
|
|
7 | (1) |
|
Economic Methods and Examples of Analysis |
|
|
8 | (2) |
|
Features of Economic Analysis |
|
|
8 | (1) |
|
Examples of Health Economics Analysis |
|
|
9 | (1) |
|
Does Economics Apply to Health and Health Care? |
|
|
10 | (1) |
|
An Example: Does Price Matter? |
|
|
10 | (1) |
|
Is Health Care Different? |
|
|
11 | (4) |
|
Presence and Extent of Uncertainty |
|
|
12 | (1) |
|
|
12 | (1) |
|
|
13 | (1) |
|
Large Role of Nonprofit Firms |
|
|
13 | (1) |
|
Restrictions on Competition |
|
|
14 | (1) |
|
|
14 | (1) |
|
Government Subsidies and Public Provision |
|
|
14 | (1) |
|
New Challenges to Health Economists -- Managed Care and Health Care Costs |
|
|
15 | (2) |
|
|
17 | (1) |
|
|
18 | (1) |
|
|
18 | (1) |
|
|
19 | (1) |
|
Microeconomic Tools for Health Economics |
|
|
20 | (33) |
|
Scarcity and the Production Possibilities Frontier |
|
|
21 | (3) |
|
Practice with Supply and Demand |
|
|
24 | (4) |
|
The Demand Curve and Demand Shifters |
|
|
24 | (1) |
|
The Supply Curve and Supply Shifters |
|
|
25 | (1) |
|
|
26 | (1) |
|
|
26 | (2) |
|
|
28 | (2) |
|
|
28 | (1) |
|
|
28 | (1) |
|
|
29 | (1) |
|
Consumer Theory: Ideas Behind the Demand Curve |
|
|
30 | (4) |
|
|
30 | (1) |
|
|
31 | (1) |
|
|
32 | (1) |
|
|
33 | (1) |
|
Individual and Market Demands |
|
|
34 | (1) |
|
|
35 | (2) |
|
Production and Market Supply |
|
|
37 | (6) |
|
|
38 | (1) |
|
|
39 | (1) |
|
|
40 | (1) |
|
Cost Minimization or Output Maximization |
|
|
41 | (1) |
|
Marginal and Average Cost Curves |
|
|
42 | (1) |
|
The Firm Supply Curve Under Perfect Competition |
|
|
43 | (3) |
|
Monopoly and Other Market Structures |
|
|
46 | (1) |
|
|
47 | (1) |
|
|
48 | (1) |
|
|
49 | (1) |
|
|
50 | (1) |
|
|
50 | (2) |
|
|
52 | (1) |
|
Statistical Tools for Health Economics |
|
|
53 | (20) |
|
|
54 | (1) |
|
|
54 | (5) |
|
The Variance of a Distribution |
|
|
55 | (1) |
|
Standard Error of the Mean |
|
|
56 | (2) |
|
Hypotheses and Inferences |
|
|
58 | (1) |
|
|
59 | (4) |
|
Ordinary Least Squares (OLS) Regressions |
|
|
60 | (1) |
|
|
61 | (1) |
|
|
62 | (1) |
|
Multiple Regression Analysis |
|
|
63 | (4) |
|
Interpreting Regression Coefficients |
|
|
64 | (1) |
|
|
65 | (2) |
|
The Identification Problem |
|
|
67 | (1) |
|
Statistical Inference in the Sciences and Social Sciences |
|
|
68 | (1) |
|
|
68 | (1) |
|
|
69 | (1) |
|
|
69 | (1) |
|
|
70 | (3) |
|
PART II: SUPPLY AND DEMAND |
|
|
73 | (114) |
|
|
73 | (23) |
|
The Production Function of Health |
|
|
73 | (3) |
|
The Historical Role of Medicine and Health Care |
|
|
76 | (7) |
|
The Rising Population and the Role of Medicine |
|
|
76 | (2) |
|
What Caused the Mortality Rate Declines? |
|
|
78 | (1) |
|
On the Role of Public Health and Nutrition |
|
|
78 | (3) |
|
What Lessons Are Learned from the Medical Historian? |
|
|
81 | (1) |
|
What Does Health Care Contribute in Total? |
|
|
82 | (1) |
|
The Production Function of Health in the Modern Day |
|
|
83 | (8) |
|
|
83 | (1) |
|
The Contribution of Health Care to Population Health: The Modern Era |
|
|
84 | (2) |
|
|
86 | (1) |
|
How Does Health Care Affect Other Measures of Health? |
|
|
87 | (1) |
|
On the Importance of Lifestyle and Environment |
|
|
88 | (1) |
|
|
89 | (1) |
|
Maternal Behavior and Newborn Health |
|
|
90 | (1) |
|
|
90 | (1) |
|
|
91 | (1) |
|
|
91 | (2) |
|
Two Different Theories About the Role of Schooling |
|
|
91 | (1) |
|
Empirical Studies on the Role of Schooling in Health |
|
|
92 | (1) |
|
|
93 | (1) |
|
|
94 | (1) |
|
|
94 | (1) |
|
|
95 | (1) |
|
The Production, Cost, and Technology of Health Care |
|
|
96 | (29) |
|
Production and the Possibilities for Substitution |
|
|
97 | (4) |
|
|
97 | (1) |
|
What Degree of Substitution Is Possible? |
|
|
98 | (1) |
|
Elasticity of Substitution |
|
|
99 | (1) |
|
Estimates for Hospital Care |
|
|
100 | (1) |
|
Costs in Theory and Practice |
|
|
101 | (9) |
|
Deriving the Cost Function |
|
|
101 | (2) |
|
|
103 | (1) |
|
Economies of Scale and Scope |
|
|
104 | (1) |
|
Why Would Economies of Scale and Scope Be Important? |
|
|
105 | (1) |
|
Empirical Cost Function Studies |
|
|
106 | (1) |
|
Differences Among Hospital Cost Studies |
|
|
107 | (1) |
|
Difficulties Faced by All Hospital Cost Studies |
|
|
107 | (2) |
|
The Evidence on Hospital Economies of Scale and Scope |
|
|
109 | (1) |
|
A Balance Between Structural and the Behavioral Studies |
|
|
109 | (1) |
|
Does Long Run Versus Short Run Matter? |
|
|
109 | (1) |
|
Summarizing These Cost Studies |
|
|
110 | (1) |
|
Technical and Allocative Inefficiency |
|
|
110 | (5) |
|
|
110 | (1) |
|
|
111 | (2) |
|
Data Envelopment Analysis |
|
|
113 | (1) |
|
The Stochastic Frontier Method |
|
|
114 | (1) |
|
Stochastic Frontier Studies |
|
|
114 | (1) |
|
Technological Changes and Costs |
|
|
115 | (3) |
|
Technological Change: Cost Increasing or Decreasing? |
|
|
115 | (1) |
|
Health Care Price Increases When Technological Change Occurs |
|
|
116 | (2) |
|
The Diffusion of New Health Care Technologies |
|
|
118 | (4) |
|
|
118 | (2) |
|
Other Factors That May Affect Adoption Rates |
|
|
120 | (1) |
|
Diffusion of Technology and Managed Care |
|
|
121 | (1) |
|
|
122 | (1) |
|
|
122 | (1) |
|
|
122 | (2) |
|
|
124 | (1) |
|
Demand for Health Capital |
|
|
125 | (16) |
|
|
125 | (2) |
|
The Consumer as Health Producer |
|
|
125 | (1) |
|
Time Spent Producing Health |
|
|
126 | (1) |
|
Labor--Leisure Trade-Offs |
|
|
127 | (2) |
|
Trading Leisure for Wages |
|
|
127 | (1) |
|
Preferences Between Leisure and Income |
|
|
128 | (1) |
|
The Investment/Consumption Aspects of Health |
|
|
129 | (2) |
|
Production of Healthy Days |
|
|
129 | (1) |
|
Production of Health and Home Goods |
|
|
130 | (1) |
|
|
131 | (1) |
|
The Demand for Health Capital |
|
|
131 | (2) |
|
Marginal Efficiency of Investment (MEI) and Rate of Return |
|
|
131 | (1) |
|
|
132 | (1) |
|
Changes in Equilibrium: Age, Wage, Education, and Uncertainty |
|
|
133 | (2) |
|
|
133 | (1) |
|
|
134 | (1) |
|
|
134 | (1) |
|
|
135 | (1) |
|
Empirical Analyses Using Grossman's Model |
|
|
135 | (3) |
|
|
138 | (1) |
|
|
138 | (1) |
|
|
139 | (1) |
|
|
139 | (2) |
|
Demand and Supply of Health Insurance |
|
|
141 | (22) |
|
|
141 | (1) |
|
Insurance Versus Social Insurance |
|
|
142 | (1) |
|
|
142 | (1) |
|
|
143 | (3) |
|
|
143 | (1) |
|
Marginal Utility of Wealth and Risk Aversion |
|
|
144 | (1) |
|
|
145 | (1) |
|
|
146 | (3) |
|
|
146 | (1) |
|
|
147 | (1) |
|
|
148 | (1) |
|
|
149 | (1) |
|
|
149 | (2) |
|
Competition and Normal Profits |
|
|
149 | (2) |
|
|
151 | (4) |
|
Demand for Care and Moral Hazard |
|
|
151 | (3) |
|
Effects of Coinsurance and Deductibles |
|
|
154 | (1) |
|
Health Insurance and the Efficient Allocation of Resources |
|
|
155 | (5) |
|
The Impact of Coinsurance |
|
|
155 | (3) |
|
The Demand for Insurance and the Price of Care |
|
|
158 | (1) |
|
The Welfare Loss of Excess Health Insurance |
|
|
159 | (1) |
|
|
160 | (1) |
|
|
160 | (1) |
|
|
161 | (1) |
|
|
161 | (2) |
|
Consumer Choice and Demand |
|
|
163 | (24) |
|
Applying the Standard Budget Constraint Model |
|
|
163 | (6) |
|
The Consumer's Equilibrium |
|
|
164 | (2) |
|
|
166 | (2) |
|
|
168 | (1) |
|
Two Additional Demand Shifters -- Time and Coinsurance |
|
|
169 | (4) |
|
|
169 | (2) |
|
|
171 | (2) |
|
Issues in Measuring Health Care Demand |
|
|
173 | (2) |
|
Individual and Market Demand Functions |
|
|
173 | (1) |
|
Measurement and Definitions |
|
|
174 | (1) |
|
Differences in the Study Populations |
|
|
174 | (1) |
|
|
174 | (1) |
|
Experimental and Nonexperimental Data |
|
|
174 | (1) |
|
Empirical Measurements of Demand Elasticities |
|
|
175 | (6) |
|
|
175 | (2) |
|
Individual Income Elasticities |
|
|
177 | (1) |
|
Income Elasticities Across Countries |
|
|
178 | (1) |
|
|
179 | (2) |
|
Impacts of Insurance on Aggregate Expenditures |
|
|
181 | (1) |
|
Other Variables Affecting Demand |
|
|
181 | (2) |
|
|
181 | (1) |
|
|
182 | (1) |
|
|
182 | (1) |
|
Age, Health Status, and Uncertainty |
|
|
182 | (1) |
|
|
183 | (1) |
|
|
183 | (1) |
|
|
184 | (1) |
|
|
185 | (2) |
|
PART III: INFORMATION AND INSURANCE MARKETS |
|
|
187 | (94) |
|
Asymmetric Information and Agency |
|
|
187 | (15) |
|
Overview of Information Issues |
|
|
187 | (1) |
|
|
188 | (4) |
|
On the Extent of Information Problems in the Health Sector |
|
|
189 | (1) |
|
Asymmetric Information in the Used-Car Market: The Lemons Principle |
|
|
190 | (2) |
|
Application of the Lemons Principle: Health Insurance |
|
|
192 | (3) |
|
Inefficiencies of Adverse Selection |
|
|
193 | (1) |
|
Experience Rating and Adverse Selection |
|
|
194 | (1) |
|
|
195 | (1) |
|
|
195 | (1) |
|
Consumer Information, Prices, and Quality |
|
|
196 | (3) |
|
Consumer Information and Prices |
|
|
196 | (1) |
|
Consumer Information and Quality |
|
|
197 | (1) |
|
|
198 | (1) |
|
|
199 | (1) |
|
|
200 | (1) |
|
|
200 | (1) |
|
|
201 | (1) |
|
Imperfect Information: Supplier-Induced Demand and Small Area Variations |
|
|
202 | (23) |
|
Supplier-Induced Demand (SID) |
|
|
202 | (3) |
|
A Common Representation of SID |
|
|
203 | (2) |
|
The Benchmark Models of SID |
|
|
205 | (5) |
|
|
205 | (3) |
|
A Profit-Maximizing Model |
|
|
208 | (1) |
|
A Synthesis of the Two Models |
|
|
209 | (1) |
|
What Do the Data Tell Us About Supplier-Induced Demand? |
|
|
210 | (5) |
|
|
211 | (1) |
|
The Identification Problem: An Algebraic Example |
|
|
211 | (2) |
|
Physician Fees, Fee Tests, and Fee Controls |
|
|
213 | (1) |
|
Empirical Evidence of Income Effects |
|
|
214 | (1) |
|
|
214 | (1) |
|
|
214 | (1) |
|
Small Area Variations (SAV) |
|
|
215 | (2) |
|
Measuring the Variations: The CV and the SCV |
|
|
216 | (1) |
|
Contributions to These Variations |
|
|
217 | (1) |
|
The Physician Practice Style Hypothesis |
|
|
217 | (2) |
|
|
217 | (2) |
|
Checking the Practice Style Hypothesis Against the Data |
|
|
219 | (3) |
|
Education, Feedback, and Surveillance |
|
|
219 | (1) |
|
Comparing Utilization Rates in Homogeneous Areas |
|
|
219 | (1) |
|
Multiple Regression Approaches |
|
|
219 | (1) |
|
SAV and the Social Cost of Inappropriate Utilization |
|
|
220 | (2) |
|
|
222 | (1) |
|
|
223 | (1) |
|
|
224 | (1) |
|
The Organization of Health Insurance Markets |
|
|
225 | (26) |
|
Loading Costs and the Behavior of Insurance Firms |
|
|
225 | (1) |
|
|
226 | (2) |
|
Insurance for Heart Attacks and Hangnails |
|
|
227 | (1) |
|
Loading Costs and the Uninsured |
|
|
227 | (1) |
|
Employer Provision of Health Insurance: Who Pays? |
|
|
228 | (6) |
|
Spousal Coverage: Who Pays? |
|
|
230 | (1) |
|
How the Tax System Influences Health Insurance Demand |
|
|
231 | (2) |
|
Who Pays -- Empirical Tests |
|
|
233 | (1) |
|
Other Impacts of Employer Provision of Health Insurance |
|
|
233 | (1) |
|
Employer-Based Health Insurance and Labor Supply |
|
|
234 | (2) |
|
Health Insurance and Retirement |
|
|
234 | (1) |
|
Health Insurance and Mobility |
|
|
234 | (2) |
|
|
236 | (3) |
|
The Market for Private Insurance |
|
|
236 | (1) |
|
|
237 | (1) |
|
|
238 | (1) |
|
The Uninsured -- An Analytical Framework |
|
|
239 | (5) |
|
|
241 | (2) |
|
The Impacts of Mandated Coverage |
|
|
243 | (1) |
|
Insurance, Technological Change, and Higher Costs |
|
|
244 | (2) |
|
The Cost-Increasing Bias Hypothesis |
|
|
244 | (1) |
|
|
245 | (1) |
|
Insurance, Technological Change, and Inflation: The Evidence |
|
|
246 | (1) |
|
Does Induced Technological Change Make the Patient Better Off? |
|
|
247 | (1) |
|
|
247 | (1) |
|
|
248 | (1) |
|
|
248 | (1) |
|
|
249 | (2) |
|
|
251 | (30) |
|
What Is the Organizational Structure? |
|
|
252 | (2) |
|
What Are the Economic Characteristics? |
|
|
254 | (1) |
|
The Emergence of Managed Care Plans |
|
|
255 | (4) |
|
Employer-Sponsored Managed Care |
|
|
255 | (2) |
|
Medicaid Managed Care Plans |
|
|
257 | (1) |
|
Managed Care Contracts with Physicians |
|
|
257 | (1) |
|
Managed Care Contracts with Hospitals |
|
|
258 | (1) |
|
Development and Growth of Managed Care -- Why Did It Take So Long? |
|
|
259 | (3) |
|
The Economics of Price Discrimination |
|
|
260 | (2) |
|
Barriers to Managed Care by Organized Medicine |
|
|
262 | (1) |
|
Federal Policy and the Growth of Managed Care |
|
|
262 | (1) |
|
|
262 | (6) |
|
|
263 | (1) |
|
|
264 | (1) |
|
|
265 | (1) |
|
|
265 | (1) |
|
Where Managed Care Differs from FFS -- Dumping, Creaming, and Skimping |
|
|
266 | (1) |
|
Equilibrium and Adverse Selection in a Market with HMOs |
|
|
266 | (2) |
|
How Does Managed Care Differ? -- Empirical Results |
|
|
268 | (4) |
|
Methodological Issues -- Selection Bias and Quality of Care |
|
|
268 | (1) |
|
Comparative Utilization and Costs |
|
|
269 | (1) |
|
The Rand Study -- A Randomized Experiment |
|
|
270 | (1) |
|
|
271 | (1) |
|
|
272 | (1) |
|
|
273 | (4) |
|
|
273 | (1) |
|
Managed Care Competition in Hospital Markets |
|
|
274 | (1) |
|
Managed Care Competition in Insurance Markets |
|
|
275 | (1) |
|
Managed Care and Technological Change |
|
|
276 | (1) |
|
|
277 | (1) |
|
|
278 | (1) |
|
|
279 | (1) |
|
|
280 | (1) |
|
PART IV: KEY PLAYERS IN THE HEALTH CARE SECTOR |
|
|
281 | (96) |
|
|
281 | (24) |
|
An Introduction to Nonprofits |
|
|
281 | (1) |
|
Why Nonprofits Exist and Why They Are Prevalent in Health Care |
|
|
282 | (7) |
|
Nonprofits as Providers of Unmet Demands for Public Goods |
|
|
282 | (4) |
|
Nonprofits as a Response to Contract Failure |
|
|
286 | (1) |
|
Applications of Contract Failure to Nursing Home Care |
|
|
286 | (1) |
|
The Role of Physicians in the Hospital Industry |
|
|
287 | (1) |
|
Financial Matters and the Nonprofit |
|
|
288 | (1) |
|
Summary of the Reasons for the Prevalence of Nonprofits |
|
|
288 | (1) |
|
Models of Nonprofit Hospital Behavior |
|
|
289 | (6) |
|
The Quality-Quantity Nonprofit Theory |
|
|
289 | (3) |
|
The Hospital as a Physicians' Cooperative |
|
|
292 | (1) |
|
A Comparison of the Quantity-Quality and the Physicians' Cooperative Theories |
|
|
293 | (2) |
|
The Evidence: Do Nonprofit Hospitals Differ from For-Profit Hospitals? |
|
|
295 | (4) |
|
|
296 | (1) |
|
Summary of Models of Hospital Behavior |
|
|
297 | (1) |
|
What Causes Conversion of Nonprofits into For-Profits? |
|
|
298 | (1) |
|
The Relative Efficiency of Nonprofits Versus For-Profits |
|
|
299 | (3) |
|
Property Rights Theory and Its Application to Nonprofits |
|
|
299 | (2) |
|
Are Nonprofit Health Care Firms Less Efficient? -- Hospital and Nursing Home Studies |
|
|
301 | (1) |
|
|
302 | (1) |
|
|
303 | (1) |
|
|
304 | (1) |
|
|
304 | (1) |
|
Hospitals and Long-Term Care |
|
|
305 | (18) |
|
Background and Overview of Hospitals |
|
|
305 | (4) |
|
|
306 | (1) |
|
|
307 | (1) |
|
Regulation and Accreditation |
|
|
308 | (1) |
|
Hospital Utilization and Costs |
|
|
309 | (5) |
|
|
310 | (1) |
|
|
311 | (2) |
|
Closures, Mergers, and Restructuring in the Hospital Industry |
|
|
313 | (1) |
|
|
314 | (5) |
|
|
314 | (1) |
|
|
315 | (1) |
|
|
316 | (2) |
|
|
318 | (1) |
|
|
319 | (1) |
|
|
320 | (1) |
|
|
321 | (1) |
|
|
322 | (1) |
|
|
322 | (1) |
|
Health Care Labor Markets and Professional Training |
|
|
323 | (28) |
|
The Demand for and Supply of Health Care Labor |
|
|
323 | (5) |
|
Production Functions and Isoquants |
|
|
324 | (1) |
|
Marginal Productivity of Labor |
|
|
325 | (1) |
|
Factor Substitution and Labor Demand |
|
|
326 | (1) |
|
|
327 | (1) |
|
Factor Productivity and Substitution Among Factors |
|
|
328 | (2) |
|
Measurement of Physician Productivity |
|
|
329 | (1) |
|
The Efficient Utilization of Physician Assistants -- Substitution Among Inputs |
|
|
329 | (1) |
|
Health Manpower Availability and the Meaning of Shortages |
|
|
330 | (6) |
|
Availability of Physicians |
|
|
330 | (2) |
|
Economic Definitions of Shortages of Health Professionals |
|
|
332 | (2) |
|
The Role of Monopsony Power -- Shortages of Registered Nurses |
|
|
334 | (2) |
|
Medical Education Issues and the Question of Control |
|
|
336 | (5) |
|
Sources of Medical School Revenues |
|
|
337 | (1) |
|
Capital Market Imperfections Justify Subsidies |
|
|
337 | (1) |
|
Teaching Hospitals, Medical Schools, and Joint Production |
|
|
337 | (1) |
|
Foreign Medical School Graduates (FMGs) |
|
|
338 | (1) |
|
The Control of Medical Education |
|
|
339 | (1) |
|
|
340 | (1) |
|
Another View -- The Donor Preference Hypothesis |
|
|
341 | (1) |
|
Licensure and Monopoly Rents |
|
|
341 | (4) |
|
Public Interest or Self-Interest |
|
|
342 | (1) |
|
|
343 | (2) |
|
Physician Pricing, Transfer Pricing, and Price Discrimination |
|
|
345 | (3) |
|
Managed Care and the Physician |
|
|
347 | (1) |
|
|
348 | (1) |
|
|
348 | (1) |
|
|
349 | (1) |
|
|
350 | (1) |
|
The Pharmaceutical Industry |
|
|
351 | (26) |
|
|
353 | (4) |
|
|
354 | (1) |
|
|
355 | (1) |
|
|
356 | (1) |
|
The Production of Health and Substitutability |
|
|
357 | (4) |
|
|
358 | (1) |
|
Insurance and Substitutability |
|
|
359 | (1) |
|
|
360 | (1) |
|
|
361 | (5) |
|
|
362 | (1) |
|
|
363 | (2) |
|
Behavior Other Than Profit-Maximizing Behavior |
|
|
365 | (1) |
|
Monopsony Pricing and Price Controls |
|
|
365 | (1) |
|
Competition and Generic Entry |
|
|
365 | (1) |
|
|
366 | (4) |
|
|
367 | (1) |
|
|
368 | (1) |
|
|
368 | (1) |
|
|
369 | (1) |
|
|
370 | (2) |
|
|
370 | (1) |
|
|
371 | (1) |
|
|
371 | (1) |
|
|
372 | (1) |
|
|
373 | (1) |
|
|
374 | (1) |
|
|
374 | (3) |
|
|
377 | (140) |
|
Equity, Efficiency, and Need |
|
|
377 | (24) |
|
Efficiency and Competitive Markets |
|
|
378 | (5) |
|
The Concept of Pareto Efficiency (Optimality) |
|
|
378 | (2) |
|
The Idea of Trading Along the Budget Line |
|
|
380 | (1) |
|
The Competitive Equilibrium |
|
|
380 | (1) |
|
The First Fundamental Theorem of Welfare Economics |
|
|
381 | (1) |
|
Redistribution of the Endowment |
|
|
381 | (1) |
|
|
382 | (1) |
|
|
383 | (1) |
|
Deviations from the Competitive Model in the Health Care Sector |
|
|
383 | (2) |
|
The Assumptions Under Perfect Competition |
|
|
383 | (2) |
|
Promoting Competition in the Health Care Sector |
|
|
385 | (1) |
|
The Theorem of the Second Best |
|
|
385 | (1) |
|
An Economic Efficiency Rationale for Social Programs in Health Care Based on Externalities |
|
|
386 | (2) |
|
Need and Need-Based Distributions |
|
|
388 | (5) |
|
Health Care Needs and the Social Welfare Function |
|
|
389 | (2) |
|
Norman Daniels's Concept of Health Care Need |
|
|
391 | (2) |
|
Horizontal Equity and Need |
|
|
393 | (2) |
|
How to Compare Horizontal Equity Among Countries |
|
|
394 | (1) |
|
|
394 | (1) |
|
Theories of Social Justice |
|
|
395 | (3) |
|
|
395 | (1) |
|
Rawls and Justice as Fairness |
|
|
396 | (1) |
|
Nozick and Entitlement Theory |
|
|
397 | (1) |
|
|
398 | (1) |
|
|
398 | (1) |
|
|
399 | (1) |
|
|
400 | (1) |
|
Government Intervention in Health Care Markets |
|
|
401 | (24) |
|
Economic Rationale for Government Intervention |
|
|
401 | (6) |
|
|
402 | (1) |
|
|
403 | (2) |
|
|
405 | (1) |
|
Other Rationales for Government Intervention |
|
|
406 | (1) |
|
Forms of Government Intervention |
|
|
407 | (3) |
|
Commodity Taxes and Subsidies |
|
|
407 | (2) |
|
|
409 | (1) |
|
|
409 | (1) |
|
|
409 | (1) |
|
Government Involvement in Health Care Markets |
|
|
410 | (3) |
|
|
410 | (1) |
|
|
410 | (1) |
|
The Veterans Administration and CHAMPUS |
|
|
411 | (1) |
|
Food and Drug Administration |
|
|
411 | (1) |
|
Mandated Health Insurance Benefits |
|
|
411 | (1) |
|
|
412 | (1) |
|
|
412 | (1) |
|
Other Government Programs |
|
|
412 | (1) |
|
|
413 | (4) |
|
Who Does the Regulator Represent? |
|
|
413 | (3) |
|
Bureaucracy and Efficiency |
|
|
416 | (1) |
|
|
417 | (5) |
|
|
418 | (1) |
|
Development of Alternative Delivery Systems |
|
|
419 | (1) |
|
|
419 | (1) |
|
|
420 | (1) |
|
Representation of the Competitive Approach |
|
|
421 | (1) |
|
|
422 | (1) |
|
|
423 | (1) |
|
|
423 | (1) |
|
|
424 | (1) |
|
Government Regulation -- Principal Regulatory Mechanisms |
|
|
425 | (29) |
|
Do the Laws of Supply and Demand Apply? |
|
|
425 | (1) |
|
|
426 | (2) |
|
|
427 | (1) |
|
Regulatory Instruments in Health Care |
|
|
427 | (1) |
|
|
428 | (1) |
|
Regulation of the Hospital Sector |
|
|
428 | (4) |
|
Rate Regulation, Utilization Review, and Certificate-of-Need |
|
|
428 | (1) |
|
Empirical Findings on Regulation |
|
|
429 | (3) |
|
|
432 | (1) |
|
|
433 | (1) |
|
The Theory of Yardstick Competition and DRGs |
|
|
433 | (7) |
|
On the Effects of Medicare's Prospective Payment System |
|
|
437 | (3) |
|
Prospective Payment -- Recent Evidence |
|
|
440 | (1) |
|
Regulation of Physician Payment |
|
|
441 | (2) |
|
UCR Reimbursement, Assignment, and Alternative Payment Mechanisms |
|
|
441 | (1) |
|
|
442 | (1) |
|
|
443 | (7) |
|
|
444 | (1) |
|
|
444 | (2) |
|
|
446 | (1) |
|
|
447 | (1) |
|
The Elzinga-Hogarty Criterion |
|
|
447 | (3) |
|
|
450 | (1) |
|
|
450 | (1) |
|
|
451 | (1) |
|
|
452 | (2) |
|
|
454 | (27) |
|
Social Insurance Policies and Social Programs |
|
|
454 | (2) |
|
|
455 | (1) |
|
Historical Roots of Social Insurance |
|
|
456 | (3) |
|
|
456 | (1) |
|
Early Experience in the United States |
|
|
457 | (1) |
|
The Establishment of Medicare and Medicaid |
|
|
458 | (1) |
|
Medicare and Medicaid in the United States |
|
|
459 | (6) |
|
|
459 | (3) |
|
|
462 | (3) |
|
The Medicaid--Medicare Relationship |
|
|
465 | (1) |
|
Children's Health Insurance Program |
|
|
465 | (1) |
|
Public Insurance and Health |
|
|
465 | (2) |
|
|
465 | (2) |
|
The Effects of Medicare and Medicaid |
|
|
467 | (10) |
|
|
467 | (7) |
|
|
474 | (1) |
|
Medicare -- Recent Changes and Future Prospects |
|
|
475 | (2) |
|
Criticisms of the American Health Care System |
|
|
477 | (1) |
|
|
478 | (1) |
|
|
479 | (1) |
|
|
479 | (1) |
|
|
480 | (1) |
|
Comparative Health Care Systems and Health System Reform |
|
|
481 | (36) |
|
Contemporary Health Care Systems |
|
|
481 | (1) |
|
A Typology of Contemporary Health Care Systems |
|
|
482 | (1) |
|
National Health Programs: Three Examples |
|
|
482 | (11) |
|
The United Kingdom -- The National Health Service |
|
|
484 | (3) |
|
|
487 | (4) |
|
|
491 | (2) |
|
The Canadian Health Care System |
|
|
493 | (6) |
|
|
493 | (3) |
|
Physician Fees and Quantity |
|
|
496 | (1) |
|
Why Are Fees and Hospital Costs Lower in Canada? |
|
|
496 | (1) |
|
|
496 | (2) |
|
|
498 | (1) |
|
Different Systems -- The Public's Evaluation |
|
|
499 | (2) |
|
Differences in Health Care Spending Across Countries |
|
|
501 | (2) |
|
A Simple Model of Health Expenditures Shares |
|
|
501 | (1) |
|
|
501 | (1) |
|
Cross-National Comparisons: Private Versus Public Financing Systems |
|
|
502 | (1) |
|
National Health Insurance |
|
|
503 | (2) |
|
Different Kinds of Possible National Health Insurance (NHI) Plans |
|
|
503 | (2) |
|
|
505 | (1) |
|
|
505 | (2) |
|
Individual Versus Employer Mandates |
|
|
505 | (2) |
|
Separation of Health Insurance from Employment |
|
|
507 | (3) |
|
Single Payer Versus Multiple Insurers |
|
|
508 | (1) |
|
Health Care Reform and International Competitiveness |
|
|
509 | (1) |
|
Providing Care at Lower Cost |
|
|
510 | (2) |
|
|
510 | (1) |
|
Managed Care and Cost Containment |
|
|
511 | (1) |
|
|
512 | (1) |
|
|
513 | (1) |
|
|
514 | (1) |
|
|
515 | (2) |
|
|
517 | (44) |
|
The Health Economics of Bads |
|
|
517 | (14) |
|
The Health Economics of Bads: An Introduction |
|
|
518 | (2) |
|
|
518 | (2) |
|
Rationales for Public Intervention |
|
|
520 | (1) |
|
|
521 | (1) |
|
Advertising Restrictions on Cigarettes and Alcohol |
|
|
521 | (4) |
|
|
522 | (1) |
|
The Possible Effects of Brand Switching |
|
|
522 | (2) |
|
Increased Demand or Brand Switching? |
|
|
524 | (1) |
|
Advertising and Alcohol Consumption |
|
|
525 | (1) |
|
Excise Taxes and Consumption: Cigarettes and Alcohol |
|
|
525 | (3) |
|
The Consumption-Reducing Effects of Excise Taxes in Theory |
|
|
525 | (1) |
|
Excise Taxes and Cigarette Consumption in Practice |
|
|
526 | (2) |
|
Excise Taxes and Alcohol Consumption |
|
|
528 | (1) |
|
|
528 | (1) |
|
|
529 | (1) |
|
|
529 | (1) |
|
|
530 | (1) |
|
Epidemiology and Economics: AIDS in Africa |
|
|
531 | (14) |
|
Concepts from Epidemiology |
|
|
531 | (2) |
|
|
533 | (4) |
|
|
533 | (1) |
|
The Prevalence Elasticity of Demand for Prevention |
|
|
534 | (1) |
|
The Economic Consequences of Epidemics |
|
|
534 | (2) |
|
The Difficulty of Eradicating Diseases |
|
|
536 | (1) |
|
|
536 | (1) |
|
The Role of Government in Battling Epidemics |
|
|
536 | (1) |
|
Case Study: AIDS in Africa |
|
|
537 | (6) |
|
|
537 | (5) |
|
Economic Theory and African Reality |
|
|
542 | (1) |
|
|
543 | (1) |
|
|
543 | (1) |
|
|
544 | (1) |
|
|
544 | (1) |
|
The Tools of Economic Evaluations |
|
|
545 | (16) |
|
Cost-Benefit Analysis: Basic Principles |
|
|
546 | (8) |
|
|
546 | (2) |
|
|
548 | (1) |
|
|
548 | (2) |
|
|
550 | (1) |
|
Distributional Adjustments |
|
|
550 | (1) |
|
|
551 | (1) |
|
|
551 | (1) |
|
Cost-Benefit Analyses of Disease-Screening Programs |
|
|
552 | (2) |
|
Cost-Effectiveness Analysis |
|
|
554 | (2) |
|
|
554 | (1) |
|
An Application: The Sixth Stool GUAIAC Test |
|
|
555 | (1) |
|
Cost--Utility Analysis, QALYs, and DALYs |
|
|
556 | (1) |
|
|
557 | (1) |
|
|
558 | (1) |
|
|
559 | (1) |
|
|
559 | (2) |
Glossary |
|
561 | (8) |
References |
|
569 | (32) |
Name Index |
|
601 | (6) |
Subject Index |
|
607 | |